These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 21247857)

  • 21. Iodine biokinetics and dosimetry in radioiodine therapy of thyroid cancer: procedures and results of a prospective international controlled study of ablation after rhTSH or hormone withdrawal.
    Hänscheid H; Lassmann M; Luster M; Thomas SR; Pacini F; Ceccarelli C; Ladenson PW; Wahl RL; Schlumberger M; Ricard M; Driedger A; Kloos RT; Sherman SI; Haugen BR; Carriere V; Corone C; Reiners C
    J Nucl Med; 2006 Apr; 47(4):648-54. PubMed ID: 16595499
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment for microcarcinoma of the thyroid--clinical experience.
    Küçük NO; Tari P; Tokmak E; Aras G
    Clin Nucl Med; 2007 Apr; 32(4):279-81. PubMed ID: 17413573
    [TBL] [Abstract][Full Text] [Related]  

  • 23. How the availability of recombinant human TSH has changed the management of patients who have thyroid cancer.
    Schlumberger M; Ricard M; De Pouvourville G; Pacini F
    Nat Clin Pract Endocrinol Metab; 2007 Sep; 3(9):641-50. PubMed ID: 17710085
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of Thyroid Hormone Withdrawal and Recombinant Human Thyrotropin on Glomerular Filtration Rate During Radioiodine Therapy for Well-Differentiated Thyroid Cancer.
    Coura-Filho GB; Willegaignon J; Buchpiguel CA; Sapienza MT
    Thyroid; 2015 Dec; 25(12):1291-6. PubMed ID: 26446582
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Robot-assisted Sistrunk's operation, total thyroidectomy, and neck dissection via a transaxillary and retroauricular (TARA) approach in papillary carcinoma arising in thyroglossal duct cyst and thyroid gland.
    Byeon HK; Ban MJ; Lee JM; Ha JG; Kim ES; Koh YW; Choi EC
    Ann Surg Oncol; 2012 Dec; 19(13):4259-61. PubMed ID: 23070784
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radioiodine remnant ablation in differentiated thyroid cancer after combined endogenous and exogenous TSH stimulation.
    Vrachimis A; Schober O; Riemann B
    Nuklearmedizin; 2012; 51(3):67-72. PubMed ID: 22294096
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changing concepts in the management of differentiated thyroid cancer.
    Intenzo CM; Jabbour S; Dam HQ; Capuzzi DM
    Semin Nucl Med; 2005 Oct; 35(4):257-65. PubMed ID: 16150246
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hürthle cell carcinoma: a clinicopathological study of thirteen cases.
    Ozlem Küçük N; Kulak H; Tokmak E; Tar P; Ibiş E; Aras G
    Nucl Med Commun; 2006 Apr; 27(4):377-9. PubMed ID: 16531925
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Follow-up of thyroid cancer patients with "poor prognosis".
    Toubert ME
    Ann Endocrinol (Paris); 2003 Feb; 64(1):68-71. PubMed ID: 12707640
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of differentiated thyroid carcinoma with radioiodine and recombinant human TSH.
    Sugino K; Ito K; Takami H
    Endocr J; 2006 Dec; 53(6):723-8. PubMed ID: 16960401
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recombinant human thyrotropin in the management of thyroid cancer.
    McDougall IR; Weigel RJ
    Curr Opin Oncol; 2001 Jan; 13(1):39-43. PubMed ID: 11148684
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Differentiated thyroid carcinoma--essential for the practitioner].
    Binz K; Haldemann A; Meier CA
    Ther Umsch; 2011 Jun; 68(6):291-5. PubMed ID: 21656486
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of paediatric thyroid carcinoma: recent experience with recombinant human thyroid stimulating hormone in preparation for radioiodine therapy.
    Lau WF; Zacharin MR; Waters K; Wheeler G; Johnston V; Hicks RJ
    Intern Med J; 2006 Sep; 36(9):564-70. PubMed ID: 16911548
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The evolving use of radioiodine therapy in differentiated thyroid cancer.
    Mayson SE; Yoo DC; Gopalakrishnan G
    Oncology; 2015; 88(4):247-56. PubMed ID: 25503797
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug therapy alternatives in the treatment of thyroid cancer.
    O'Doherty MJ; Coakley AJ
    Drugs; 1998 Jun; 55(6):801-12. PubMed ID: 9617595
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Papillary and follicular cancers of the thyroid].
    Schlumberger M; Baudin E; Travagli JP
    Presse Med; 1998 Oct; 27(29):1479-81. PubMed ID: 9798467
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insular variant of poorly differentiated thyroid carcinoma.
    Fat I; Kulaga M; Dodis R; Carling T; Theoharis C; Rennert NJ
    Endocr Pract; 2011; 17(1):115-21. PubMed ID: 20634178
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognosis and treatment of brain metastases in thyroid carcinoma.
    Chiu AC; Delpassand ES; Sherman SI
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3637-42. PubMed ID: 9360519
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer.
    ; Cooper DS; Doherty GM; Haugen BR; Kloos RT; Lee SL; Mandel SJ; Mazzaferri EL; McIver B; Pacini F; Schlumberger M; Sherman SI; Steward DL; Tuttle RM
    Thyroid; 2009 Nov; 19(11):1167-214. PubMed ID: 19860577
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Approach to the thyroid cancer patient with extracervical metastases.
    Haugen BR; Kane MA
    J Clin Endocrinol Metab; 2010 Mar; 95(3):987-93. PubMed ID: 20203334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.